Name: Novel Therapeutic Agents for the Treatment of Autoimmune Diseases
ISBN: 9780429082610

Book

Novel Therapeutic Agents for the Treatment of Autoimmune Diseases

ABSTRACT

Provides a detailed survey of therapies for autoimmune diseases, exploring the rationale for their use and clinical data regarding their potential benefit.

chapter 1|10 pages

The Evaluation of Biological Agents

part II|2 pages

Cellular Targeted Therapies

chapter 2|14 pages

Anti-CD5/Ricin A Chain lmmunoconjugate Therapy in Rheumatoid Arthritis

chapter 3|16 pages

Early Clinical Studies of IL-2 Fusion Toxin in Patients with Severe Rheumatoid Arthritis, Recent-Onset Insulin-Dependent Diabetes Mellitus, and Psoriasis

chapter 4|14 pages

Chimeric Anti-CD4 Antibody as a Potential Therapeutic Agent for Rheumatoid Arthritis

chapter 5|10 pages

CD4 Monoclonal Antibody Therapy in Rheumatoid Arthritis

chapter 6|10 pages

The Use of CE9.1, a Primatized Monoclonal Anti-CD4, in the Treatment of Rheumatoid Arthritis

chapter 7|8 pages

CAMPATH-1H Therapy in Autoimmune Diseases

chapter 8|12 pages

CAMPATH-1 Hin Rheumatoid Arthritis United States Experience

part III|2 pages

Cytokine Targeted Therapies

chapter 9|12 pages

Interferon-Gamma in the Treatment of Rheumatoid Arthritis

chapter 10|14 pages

Tumor Necrosis Factor Blockade in Rheumatoid Arthritis

chapter 11|10 pages

Engineered Human Anti-Tumor Necrosis Factor-Alpha (TNFα) Antibody, CDP571, in Rheumatoid Arthritis

chapter 12|10 pages

Clinical Experience with Recombinant Humanlnterleukin-1 Receptor Type I (Rhu IL-1 RI) in Patients with Rheumatoid Arthritis

chapter 13|14 pages

Treatment of Rheumatoid Arthritis with Soluble Tumor Necrosis Factor Receptor

part IV|2 pages

Adhesion Molecule Targeted Therapies

chapter 14|18 pages

Treatment of Rheumatoid Arthritis with a Monoclonal Antibody to Intercellular Adhesion Molecule-1

part V|2 pages

Potential Antigen-Specific Therapies

chapter 15|16 pages

T-Cell-Receptor Peptide Therapy for Multiple Sclerosis

chapter 16|12 pages

T-Cell-Receptor Peptide Vaccination Studies in Rheumatoid Arthritis

chapter 17|20 pages

Oral Tolerance for the Treatment of Autoimmune Disease

chapter 18|14 pages

Oral Tolerance

chapter 19|22 pages

Intravenous lmmunoglobulin (IVIg) in the Treatment of Autoimmune Diseases

part VI|2 pages

Purine and Pyrimidine Synthesis Inhibitors

chapter 20|30 pages

Inhibitors of De Novo Nucleotide Synthesis in the Treatment of Rheumatoid Arthritis

Novel Therapeutic Agents for the Treatment of Autoimmune Diseases